Pipeline
Developing a pipeline of novel candidates focused on unmet medical needs for patients
Our Science
At DeepCure, we are focused on discovering and developing novel small molecule drugs focused on areas of high unmet medical need.
Early Discovery
Late Discovery
IND-Enabling
Phase I
Brd4
Systemic indications (oral)
Late Discovery
Brd4
Cutaneous indications (topical)
Late Discovery
Brd4
Ophthalmic indications
Early Discovery
Wee1
Multiple indications (oral)
Early Discovery
2 Undisclosed
Inflammation/Immune indications
Early Discovery